Advertisement

Topics

Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure Candidate from Astellas

09:00 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company expanding pipeline of novel treatments for cardiovascular disease Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of ...

Other Sources for this Article

W2Opure
Stephanie Hutton, 910-726-1367
shutton@w2ogroup.com

NEXT ARTICLE

More From BioPortfolio on "Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure Candidate from Astellas"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...